Synexis and Quip Laboratories are collaborating to satisfy the growing demand for advanced microbial reduction technologies in life sciences research environments. Quip Laboratories’ 40-year history of specialized facility hygiene solutions enables US Life Sciences customers to efficiently procure, deploy, and scale Synexis DHP technology for enhanced pathogen control.

Through consultative partnerships and a service-first approach, Quip Labs serves as a single source for comprehensive biosecurity solutions that protect research integrity and simplify facility operations. This collaboration enables facilities to access complementary pathogen control technologies through a single vendor. Synexis DHP technology provides continuous microbial reduction in the air and on surfaces and is safe for use in occupied spaces. This continuous sanitary pressure complements Quip Labs’ Halo Disinfection System, which provides 6-log efficacy for terminal decontamination.

“After 40 years serving life sciences research, we know that comprehensive pathogen control is essential to protecting research integrity,” said Nick Hidell, President at Quip Laboratories. “Synexis is an excellent complement to our Halo whole-room disinfection system’s 6-log sporicidal efficacy. Together, they deliver continuous pathogen control that works around the clock to support uninterrupted operations.“

“The rise of emerging pathogens, combined with growing pressure to use resources more efficiently, is reshaping how organizations think about microbial control,” said Dennis Doyle, CEO of Synexis. “Our work with Quip Laboratories expands what’s possible for the life sciences industry by offering our touchless, continuous pathogen control technology.”

Synexis DHP technology is available now to Life Sciences customers through Quip Labs. Research facilities can contact Quip Labs by phone at 1-800-424-2436, email at info@quiplabs.com, or visit www.quiplabs.com.

About Synexis

Since 2008, Synexis has been an industry leader delivering continuous pathogen control technology that is intentionally designed for occupied environments.

Synexis makes customer environments healthier and safer with Dry Hydrogen Peroxide (DHP®) patented technology — a continuous, proactive method for reducing surface-level and airborne pathogens.

Synexis patented devices have undergone rigorous testing by Underwriters Laboratories (UL) and are certified to meet UL2998 for zero ozone emissions and can run 24/7 within occupied spaces. Synexis systems are regulated by the US Environmental Protection Agency and state governments. Synexis devices are produced in EPA-registered facilities and packaged and labeled in accordance with EPA regulations appearing at 40 CFR 152.500. Peer-reviewed research and other resources can be found on www.synexis.com.

About Quip Laboratories

At Quip Laboratories, we believe the greatest chemistry happens between people. As chemists, formulators, and innovative solutions providers, we develop advanced chemical technologies that reduce infection risk, streamline operations, and protect groundbreaking work in critical industries like healthcare and life sciences. From EPA-registered disinfectants, whole-room disinfection systems, and proprietary cage washing chemistries to our QuipDecon, PurityGard, and MaestroChem Chemical Management turnkey services, Quip Laboratories provides comprehensive biosafety solutions for life sciences, veterinary, and healthcare facilities. Founded in 1985 and family-owned for 40 years, Quip Labs maintains an exclusive focus on life sciences research. Visit www.quiplabs.com or call 1-800-424-2436

Media Contact:

Kyle DeBruhl

Director of Marketing
Quip Laboratories
Kyle@quiplabs.com

602.399.5953

Synexis Contact:

Colin Henthorne
Channel Account Executive
chenthorne@synexis.com